Cargando…
Subsequent MRI of pediatric patients after an adverse reaction to Gadolinium-based contrast agents
BACKGROUND: Gadolinium-based contrast agent (GBCA)-enhanced magnetic resonance imaging (MRI) scans often must be used repeatedly in pediatric oncologic patients. Although GBCAs are usually well tolerated, severe and life-threatening allergic reactions might occur, which can result in overly cautions...
Autores principales: | Hojreh, Azadeh, Peyrl, Andreas, Bundalo, Aleksandra, Szepfalusi, Zsolt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122741/ https://www.ncbi.nlm.nih.gov/pubmed/32243440 http://dx.doi.org/10.1371/journal.pone.0230781 |
Ejemplares similares
-
Fatal anaphylactic reaction to intravenous gadobutrol, a gadolinium-based MRI contrast agent
por: Franckenberg, Sabine, et al.
Publicado: (2017) -
Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents
por: Jeong, Sang Young, et al.
Publicado: (2010) -
Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents
por: Thomsen, Henrik S., et al.
Publicado: (2007) -
Immediate reaction to gadolinium based contrast agent with fatal outcome()()()
por: Behzadi, Ashkan Heshmatzadeh, et al.
Publicado: (2018) -
Gadolinium contrast agents: Over exposure?
por: Biederman, Robert W, et al.
Publicado: (2016)